Zoetis Boosts Dividend After Ackman Raises Stake

Zoetis Inc., the animal drug company that activist investor Bill Ackman has taken a stake in, boosted its quarterly dividend by 15 percent.

The revised dividend is 8.3 cents a share, payable March 3 to stockholders as of Jan. 22, the Florham Park, New Jersey-based company said today in a statement. Zoetis was expected to raise the payment to 8 cents, from 7.2 cents currently, according to data compiled by Bloomberg.

“We continued to demonstrate the strength of our business model and deliver our long-term value proposition, including returning capital to our shareholders through our quarterly dividends,” Chief Executive Officer Juan Ramon Alaix said in the statement.

Ackman sees a big opportunity to cut costs at the company, people familiar with the matter said last month. Zoetis adopted a shareholder rights plan to help block a hostile takeover after Ackman’s Pershing Square Capital Management said on Nov. 12 that it was acquiring a stake of about 8.5 percent. Activist investors often apply pressure for a sale, restructuring or increased dividends and share buybacks.

Pershing Square held 41.6 million shares of Zoetis, or 8.3 percent, as of Dec. 4 and is the drug company’s largest stockholder, according to data compiled by Bloomberg. Zoetis was spun off by Pfizer Inc. last year.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE